Buscar
Mostrando ítems 1-10 de 14
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
(Elsevier B.V., 2014-04-01)
Ceftobiprole is a broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative pathogens including Pseudomonas aeruginosa. the aim of this study was to evaluate ...
Ceftobiprole Activity against over 60,000 Clinical Bacterial Pathogens Isolated in Europe, Turkey, and Israel from 2005 to 2010
(Amer Soc Microbiology, 2014-07-01)
Ceftobiprole medocaril is a newly approved drug in Europe for the treatment of hospital-acquired pneumonia (HAP) (excluding patients with ventilator-associated pneumonia but including ventilated HAP patients) and ...
Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study
(Brazilian Society of Infectious Diseases, 2011-08-01)
Ceftobiprole is a broad-spectrum cephalosporin with potent activity against staphylococci, including those resistant to oxacillin, as well as against most Gram-negative bacilli including Pseudomonas aeruginosa. In this ...
Novel beta-Lactams
(Contexto, 2008-10-01)
The beta-lactam class constitutes the largest group of antimicrobial agents, which includes penicillins, cephalosporins, monobactams, and carbapenems. These compounds, which have in common the beta-lactam ring in their ...
Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model
(Journal of Antimicrobial Chemotherapy, 2007)
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including β-lactamase-producing and vancomycin-resistant isolates
(American Society for MicrobiologyAntimicrobial agents and chemotherapy, 2007)
Resistance to last resort antibiotics in gram-positive cocci: the post-vancomycin era
(Instituto Nacional de Salud de Colombia, 2014)
New therapeutic alternatives have been developed in the last years for the treatment of multidrug-resistant Gram-positive infections. Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant ...
Resistance to last resort antibiotics in gram-positive cocci: the post-vancomycin era
(Instituto Nacional de Salud de Colombia, 2014)
New therapeutic alternatives have been developed in the last years for the treatment of multidrug-resistant Gram-positive infections. Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant ...
Resistencia a antibióticos de última línea en cocos Gram positivos: la era posterior a la vancomicina
(Instituto Nacional de SaludBiomédica : Revista del Instituto Nacional de Salud, 2014)
En los últimos años se han desarrollado nuevas alternativas para el tratamiento de infecciones por patógenos Gram positivos multirresistentes, entre los cuales Staphylococcus aureus resistente a la meticilina (SARM) y los ...
Dinâmica temporal de Staphylococcus aureus resistentes à oxacilina recuperados de infecções de corrente sanguínea em um hospital terciário da cidade de São Paulo em um período de 13 anos
(Universidade Federal de São Paulo, 2022-01-24)
Infecções causadas por Staphylococcus aureus Resistentes à Oxacilina (ORSA) são
mundialmente estabelecidas como um problema de saúde pública, uma vez que, o
potencial de patogenicidade de S. aureus tem grande ...